Swiss Life Holding AG (SWSDF) reports a 3% increase in profit from operations and proposes a 4% dividend hike, maintaining robust financial health.

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The FSB’s updated list now includes 17 insurers, up from 13 last year.

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Swiss Life Holding (SWX:SLHN) has quietly outperformed in recent months, delivering a 6% gain over the past 3 months and nearly 20% year-to-date. Investors are watching to see if these returns reflect underlying business strength. See our latest analysis for Swiss Life Holding. Swiss Life Holding’s share price has steadily built momentum this year, closing at CHF 851.8 after a strong run that is reflected in its robust year-to-date gains. More impressively, its 1-year total shareholder return...

The cider brand has added a high-contrast NaviLens QR code to its cans.

BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty

Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a promising targeted therapy with the potential to reduce systemic inflammation, as a treatment option for atherosclerotic cardiovascular disease, Novartis said in a statement. With the deal, Novartis will acquire a Phase III-ready asset that will complement its existing cardiovascular disease portfolio, it said.

Swiss Life Holding ( VTX:SLHN ) First Half 2025 Results Key Financial Results Revenue: CHF5.74b (down 5.5% from 1H...